Department of Neurology

Research - Clinical Research - Stroke

Purpose of Stroke Research

  • Speed the development of treatments and preventions
  • Gain better understanding of the disease
  • Improve quality of life for stroke patients

Current Study on Stroke Prevention:  

Platelet-Oriented Inhibition in New TIA and minor ischemic stroke (POINT) Trial; In collaboration with the University of California, San Francisco; supported by the National Institute of Neurological Disorders and Stroke (NINDS)

Acute stroke studies

The thrombolytic agent desmoteplase is a  naturally occurring protease found in the in the saliva of the bat Desmodus rotundus. Desmoteplase dissolves occluding blood clots and restores blood flow to the affected brain area  in a time-window extending up to 9 hours after symptom onset.

You may be eligible to participate if you have a diagnosis of stroke based on a physical examination conducted by a neurologist.  Administration of the study medication is to begin within 9 hours of stroke symptoms

For more information on the UTMC stroke program contact:

Andrea Korsnack, RN, Certified Clinical Research Coordinator * 419-383-3801 *



Last Updated: 6/27/22